Quarterly Results 1 post

• Novo Nordisk 2021Q3 - Wegovy® bottlenecks
  13 November 2021  ·  2021Q3 Denmark Diabetes
  Novo Nordisk continues to succeed in the GLP-1 space with semaglutide ( Ozempic ®, Rybelsus ® and Wegovy ®).